Probing the communication patterns of different chondrocyte subtypes in osteoarthritis at the single cell level using pattern recognition and manifold learning.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 09 2023
Historique:
received: 20 05 2023
accepted: 01 09 2023
medline: 4 9 2023
pubmed: 3 9 2023
entrez: 2 9 2023
Statut: epublish

Résumé

The patterns of communication among different chondrocyte subtypes in human cartilage degeneration and regeneration help us understand the microenvironment of osteoarthritis and optimize cell-targeted therapies. Here, a single-cell transcriptome dataset of chondrocytes is used to explore the synergistic and communicative patterns of different chondrocyte subtypes. We collected 1600 chondrocytes from 10 patients with osteoarthritis and analyzed the active communication patterns for the first time based on network analysis and pattern recognition at the single-cell level. Manifold learning and quantitative contrasts were performed to analyze conserved and specific communication pathways. We found that ProCs (Proliferative chondrocytes), ECs (Effector chondrocytes), preHTCs (Prehypertrophic chondrocytes), HTCs (Hypertrophic chondrocytes), and FCs (Fibrocartilage chondrocytes) are more active in incoming and outgoing signaling patterns, which is consistent with studies on their close functional cooperation. Among them, preHTCs play multiple roles in chondrocyte communication, and ProCs and preHTCs have many overlapping pathways. These two subtypes are the most active among all chondrocyte subtypes. Interestingly, ECs and FCs are a pair of "mutually exclusive" subtypes, of which ECs are predominant in incoming patterns and FCs in outgoing patterns. The active signaling pathways of ECs and FCs largely do not overlap. COLLAGEN and LAMININ are the main pivotal pathways, which means they are very important in the repair and expansion of joint homeostasis. Notably, only preHTCs assume multiple roles (including sender, receiver, mediator, and influencer) and are involved in multiple communication pathways. We have examined their communication patterns from the perspective of cellular interactions, revealed the relationships among different chondrocyte subtypes, and, in particular, identified a number of active subtypes and pathways that are important for targeted therapy in the osteoarthritic microenvironment. Our findings provide a new research paradigm and new insights into understanding chondrocyte activity patterns in the osteoarthritic microenvironment.

Identifiants

pubmed: 37660146
doi: 10.1038/s41598-023-41874-z
pii: 10.1038/s41598-023-41874-z
pmc: PMC10475121
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14467

Informations de copyright

© 2023. Springer Nature Limited.

Références

Dev Cell. 2012 Mar 13;22(3):597-609
pubmed: 22421045
Genome Biol. 2022 Dec 13;23(1):256
pubmed: 36514162
Bone Res. 2022 Apr 27;10(1):38
pubmed: 35477573
Cell. 2004 Nov 12;119(4):555-66
pubmed: 15537544
Nat Rev Mol Cell Biol. 2020 Jun;21(6):327-340
pubmed: 32235894
Front Cell Dev Biol. 2023 Apr 04;11:1099287
pubmed: 37082621
Matrix Biol. 2016 Mar;50:1-15
pubmed: 26454027
Osteoarthritis Cartilage. 2015 Dec;23(12):2259-2268
pubmed: 26162802
Nat Commun. 2021 Feb 17;12(1):1088
pubmed: 33597522
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Nat Rev Genet. 2023 Aug;24(8):494-515
pubmed: 36864178
Nat Rev Nephrol. 2021 Nov;17(11):710-724
pubmed: 34417589
Matrix Biol. 2018 Oct;71-72:40-50
pubmed: 29800616
Osteoarthritis Cartilage. 2019 May;27(5):823-832
pubmed: 30711608
Gene. 2023 Feb 5;852:147063
pubmed: 36427677
Nat Rev Genet. 2021 Oct;22(10):627-644
pubmed: 34145435
Front Cell Dev Biol. 2021 May 28;9:664168
pubmed: 34124045
Bone Res. 2021 Aug 16;9(1):37
pubmed: 34400611
Ann Rheum Dis. 2019 Jan;78(1):100-110
pubmed: 30026257
EBioMedicine. 2022 Oct;84:104258
pubmed: 36137413
Nat Commun. 2021 Jan 13;12(1):362
pubmed: 33441552
Nat Med. 2010 Jun;16(6):678-86
pubmed: 20495570
Endocr Dev. 2011;21:12-22
pubmed: 21865750
Biochem Pharmacol. 2019 Jul;165:49-65
pubmed: 30853397
Ann N Y Acad Sci. 2019 Apr;1442(1):17-34
pubmed: 30008181
Endocr Rev. 2015 Dec;36(6):646-80
pubmed: 26485225
Ann Rheum Dis. 2015 Apr;74(4):703-10
pubmed: 24363360
Ann Rheum Dis. 2015 Mar;74(3):490-8
pubmed: 24288012
Mol Cell. 2022 Jun 16;82(12):2335-2349
pubmed: 35714588
Curr Osteoporos Rep. 2022 Oct;20(5):356-362
pubmed: 35915289
Arthritis Res Ther. 2006;8(5):R149
pubmed: 16972994
Anat Embryol (Berl). 1992 Jul;186(2):107-24
pubmed: 1510240
Nature. 2013 Mar 21;495(7441):375-8
pubmed: 23485973
Bioengineered. 2021 Dec;12(1):997-1007
pubmed: 33749514
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12097-102
pubmed: 25092332
Genes Dev. 1999 Aug 15;13(16):2072-86
pubmed: 10465785
Br J Radiol. 2015 Aug;88(1052):20140542
pubmed: 26081446
Cell. 2014 Feb 13;156(4):730-43
pubmed: 24529376
Ageing Res Rev. 2018 Mar;42:56-71
pubmed: 29258883
Ann Rheum Dis. 2016 Nov;75(11):e72
pubmed: 27543413
Instr Course Lect. 1998;47:477-86
pubmed: 9571449

Auteurs

Jiajian Wang (J)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China. jiajianwang2019@gmail.com.
Shenzhen Key Laboratory of Metabolic Health, Center for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. jiajianwang2019@gmail.com.
Shenzhen Key Laboratory of Metabolic Health, Shenzhen, 518055, China. jiajianwang2019@gmail.com.
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. jiajianwang2019@gmail.com.

Caihong Liu (C)

School of Medicine, The Chinese University of Hong Kong, Shenzhen, Shenzhen, 518172, China.

Litao Yang (L)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

Huixiong Chen (H)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

Mingqi Zheng (M)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

Yanbin Wan (Y)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

Xiongxin Hong (X)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

Sidi Li (S)

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.

Jing Han (J)

Warshel Institute for Computational Biology, School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, Shenzhen, 518172, China.

Ruibin Luo (R)

Department of Clinical Laboratory, Longgang District Central Hospital of Shenzhen, Shenzhen, 518116, Guangdong, China.

Xing Wan (X)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

Jian V Zhang (JV)

Shenzhen Key Laboratory of Metabolic Health, Center for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. jian.zhang@siat.ac.cn.
Shenzhen Key Laboratory of Metabolic Health, Shenzhen, 518055, China. jian.zhang@siat.ac.cn.
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. jian.zhang@siat.ac.cn.

Ruihuan Xu (R)

Clinical Laboratory Department of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China. xrh69@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH